News & Events about United Therapeutics Corporation.
United Therapeutics Co. (NASDAQ:UTHR Get Rating) CEO Martine A. Rothblatt sold 8,000 shares of the companys stock in a transaction on Friday, January 27th. The stock was sold at an average price of $260.01, for a total transaction of $2,080,080.00. Following the completion of the ...
United Therapeutics Co. (NASDAQ:UTHR Get Rating) CEO Martine A. Rothblatt sold 8,000 shares of the businesss stock in a transaction dated Friday, January 27th. The stock was sold at an average price of $260.01, for a total value of $2,080,080.00. Following the transaction, the chief executive ...
United Therapeutics Co. (NASDAQ:UTHR Get Rating) CEO Martine A. Rothblatt sold 8,000 shares of the stock in a transaction that occurred on Wednesday, January 25th. The stock was sold at an average price of $264.21, for a total value of $2,113,680.00. Following the transaction, the chief executive ...
United Therapeutics Co. (NASDAQ:UTHR Get Rating) CEO Martine A. Rothblatt sold 8,000 shares of the companys stock in a transaction on Monday, January 23rd. The stock was sold at an average price of $258.97, for a total value of $2,071,760.00. Following the transaction, the chief ...
United Therapeutics Co. (NASDAQ:UTHR Get Rating) CEO Martine A. Rothblatt sold 8,000 shares of the businesss stock in a transaction dated Thursday, January 19th. The stock was sold at an average price of $259.60, for a total value of $2,076,800.00. Following the completion of the sale...